ChartMill assigns a Buy % Consensus number of 60% to PRAH. The Buy consensus is the weighted average rating of the current analysts ratings.
4 analysts have analysed PRAH and the average price target is 171.11 null. This implies a price increase of 3.57% is expected in the next year compared to the current price of 165.21.
The consensus rating for Pra Health (PRAH) is 60 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering Pra Health (PRAH) is 4.